Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]
Paulo Roberto Barbosa Evora
Critical Care London v. 22, art. 104, 2018London 2018
Localização: FMRP - Fac. Medicina de Ribeirão Preto (pcd 2938483 Estantes Deslizantes )(Acessar)